Merck President of Global Human Health to Step Down

Merck & Co. Inc. (MRK) on Monday said Adam H. Schechter, president of Global Human Health, is stepping down from his current position as of Dec. 31, and will be shifting to an advisory capacity to the chief executive.

In addition, Merck said it "is taking the opportunity to reshape its commercial organization and is creating two new Executive Committee roles," promoting Frank Clyburn to chief commercial officer and Michael Nally to chief marketing officer.

Mr. Schechter, who joined the company in 1988, has been the president of Merck's human health business since 2010.

"Adam's leadership and unwavering dedication to finding new ways to bring Merck's medicines and vaccines to more patients around the world have been hallmarks of his time at Merck," Merck Chairman and Chief Executive Officer Kenneth C. Frazier said in a statement. "I have relied on his experience and expertise as we evolved a world-class commercial organization, spanning primary care, hospital and specialty, vaccines and oncology. Because of him we are better positioned to address future opportunities and challenges as a global biopharmaceutical company, and Frank and Mike have a great foundation upon which to build future success."

Mr. Clyburn and Mr. Nally will start their new roles on Jan. 1, 2019. Mr. Clyburn most recently has served as president of the Global Oncology business. Mr. Nally most recently led the company's Vaccines business.

Write to copydesk@dowjones.com

(END) Dow Jones Newswires

December 10, 2018 17:10 ET (22:10 GMT)

Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024